Stay updated with breaking news from Maternal Immunization Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer's Abrysvo vaccine prevents RSV-induced LRTD in infants. It's given as a single-dose injection to pregnant individuals between 32 to 36 weeks of gestation.
Respiratory Syncytial Virus (RSV) is a global pathogen that can cause severe respiratory tract illness. RSV infections can be especially dangerous for newborns and infants in general. A large-scale international vaccination study involving Charité – Universitätsmedizin Berlin and the London School of Hygiene and Tropical Medicine has now investigated the efficacy of an initial vaccine candidate. Participants were given the vaccine during pregnancy. As the researchers describe in The New England Journal of Medicine*, up to 81 percent of the participants’ children were reliably protected a...
Does immunising a woman during pregnancy protect her unborn baby against respiratory syncytial virus (RSV) in the months after it is born?
Plus, new MELODY data confirm protection against RSV for babies receiving long-acting antibody